A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

For all the buzz surrounding weight loss medications like semaglutide and tirzepatide, these drugs aren’t perfect. They come with a risk of side effects like nausea and diarrhea ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its lowest dose level.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Semaglutide, the drug sold as Wegovy for weight-loss and Ozempic for diabetes, is still currently in shortage in the U.S. according to the Food and Drug Administration. Novo Nordisk has committed ...

“This is despite trying to stick with the healthy eating and regular physical activity that was helping them lose weight in the first place.” Lemieux said weight gain after semaglutide use ...

Zoho offers its own Gantt chart tool that operates based on a drag-and-drop interface, so you just need to drag and drop between task bars to define relationships and dependencies. This tool ...